Pan Tex Medical Technology Investments Inc is categorized under Medical Research in San Antonio, TX and active since 1993.
Pan Tex Medical Technology Investments Inc was established in 1993, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Tim Herring at the company’s single location by writing to 19210 Huebner Road # 200, San Antonio, Texas TX 78258 or by phoning (650) 598-0700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pan Tex Medical Technology Investments Inc |
Contact Person: | Tim Herring |
Address: | 19210 Huebner Road # 200, San Antonio, Texas 78258 |
Phone Number: | (650) 598-0700 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Pan Tex Medical Technology Investments Inc was started in 1993 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Tim Herring for inquiries that concern Pan Tex Medical Technology Investments Inc by calling the company number (650) 598-0700, as your correspondence is most welcome. Additionally, the physical location of the single location of Pan Tex Medical Technology Investments Inc can be found at the coordinates as well as the street address 19210 Huebner Road # 200 in San Antonio, Texas 78258.
For its online presence, you may visit Pan Tex Medical Technology Investments Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.